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Background-—Whether ventricular arrhythmias (VAs) represent a feature of the adaptive changes of the athlete’s heart remains
elusive. We aimed to assess the prevalence, determinants, and underlying substrates of VAs in young competitive athletes.
Method and Results-—We studied 288 competitive athletes (age range, 16–35 years; median age, 21 years) and 144 sedentary
individuals matched for age and sex who underwent 12-lead 24-hour ambulatory electrocardiographic monitoring. VAs were
evaluated in terms of number, complexity (ie, couplet, triplet, or nonsustained ventricular tachycardia), exercise inducibility, and
morphologic features. Twenty-eight athletes (10%) and 13 sedentary individuals (11%) showed >10 isolated premature ventricular
beats (PVBs) or ≥1 complex VA (P=0.81). Athletes with >10 isolated PVBs or ≥1 complex VA were older (median age, 26 versus 20
years; P=0.008) but did not differ with regard to type of sport, hours of training, and years of activity compared with the remaining
athletes. All athletes with >10 isolated PVBs or ≥1 complex VA had a normal echocardiographic examination; 17 of them showing
>500 isolated PVBs, exercise-induced PVBs, and/or complex VA underwent additional cardiac magnetic resonance, which
demonstrated nonischemic left ventricular late gadolinium enhancement in 3 athletes with right bundle branch block PVBs
morphologic features.
Conclusions-—The prevalence of >10 isolated PVBs or ≥1 complex VA at 24-hour ambulatory electrocardiographic monitoring did
not differ between young competitive athletes and sedentary individuals and was unrelated to type, intensity, and years of sports
practice. An underlying myocardial substrate was uncommon and distinctively associated with right bundle branch block VA
morphologic features. ( J Am Heart Assoc. 2018;7:e009171. DOI: 10.1161/JAHA.118.009171.)
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T he leading causes of malignant arrhythmic events andsudden cardiac death (SCD) in the athlete include
cardiomyopathies that predispose to the abrupt onset of
sustained ventricular tachycardia (VT) or ventricular fibrillation
during exercise.1 As a consequence, to detect ventricular
arrhythmias (VAs) on the athlete’s ECG raises concern of an
underlying cardiac disease at risk of SCD.2,3 Interpretation of
VA in athletes with no overt structural abnormalities is still a
matter of debate.
A milestone study on elite athletes found that most VA
occur in the absence of an underlying heart disease and tend
to disappear with detraining, suggesting that they may be
considered a feature of the adaptive changes of the athlete’s
heart.4,5 However, these findings were limited to a single-
center experience and were not in keeping with the results of
old studies performed in the 1980s and 1990s, which
demonstrated no differences in the VA burden at 24-hour
ambulatory electrocardiographic monitoring between athletes
and sedentary individuals.6–11 Moreover, these previous
investigations focused on the number and complexity of
VAs without characterizing the morphologic features of
premature ventricular beats (PVBs), a parameter that may
help to identify the site of origin of the arrhythmia and the
possible underlying myocardial substrate.12
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The present study was designed to compare the burden of
VAs recorded by 24-hour 12-lead ambulatory electrocardio-
graphic monitoring in a large cohort of apparently healthy
young athletes with that of sedentary individuals and to
evaluate the association between VAs and the intensity,
duration, and type of training. Athletes with >10 isolated
PVBs/hour or ≥1 complex VA (ie, ≥1 couplet, triplet, or
nonsustained VT) underwent an imaging study to assess the
presence of an underlying myocardial substrate.
Methods
The data that support the findings of this study are available
from the corresponding author on reasonable request.
Athletes
The study protocol was approved by the local Ethical
Committee, and all subjects (or parents/guardians if subjects
were <18 years old) gave written informed consent. Partic-
ipants were not paid.
Athletes were recruited at the Center of Sports Medicine,
Public Health System (Padova, Italy) from September 1, 2015
to December 23, 2016, which was the time period required to
enroll the prespecified number of individuals. According to the
Italian law, all athletes engaged in competitive sports activity
must undergo preparticipation cardiovascular evaluation,
including family and personal history, physical examination,
resting 12-lead ECG, and exercise testing. Further examina-
tions are reserved to athletes showing abnormalities at first-
line investigations. Athletes who were considered eligible for
competitive sports activity on the basis of preparticipation
screening and fulfilled the inclusion criteria were offered
participation in the study. Inclusion criteria were the following:
(1) age range from 15 to 35 years; (2) engagement in all
competitive sports, with the exception of disciplines at low
static/low dynamic cardiovascular demand, according to the
classification of Mitchell et al13; (3) ≥6 hours of exercise per
week; (4) no known structural cardiovascular disease, exclud-
ing mild valvular disease or previous myocarditis/pericarditis
that was considered clinically healed; (5) no contraindications
to contrast-enhanced cardiac magnetic resonance (CMR); and
(6) availability to undergo imaging investigations in addition to
electrocardiographic monitoring, if required.
At the time of enrollment, the following information was
collected: the type of sport (in case of multiple disciplines,
that accounting for the majority of training hours was
considered), hours of training per week, cumulative years of
practice of competitive sport activity, previous symptoms, and
family history of premature sudden death (<50 years old in
women and <40 years old in men), coronary artery disease, or
cardiomyopathy in first-degree relatives.
Sedentary Individuals
A group of sedentary subjects, who were engaged in ≤2 hours
per week of leisure-time physical exercise and matched to
athletes for sex and age class (≤25 and >25 years old) with a
1:2 ratio, was recruited with advertisement in the local press
and social media during the same time period. Except for
sports activity, inclusion criteria were the same of athletes: in
particular, sedentary individuals had to have a negative history
of cardiac disease (including arrhythmias). Information about
previous symptoms and family history was collected at the
time of enrollment.
Ambulatory Electrocardiographic Monitoring
Twelve-lead 24-hour ambulatory electrocardiographic moni-
toring (H12+; Mortara Instruments Inc) was performed in all
study participants. Athletes were asked to perform a training
session of at least 30 to 60 minutes during the ambulatory
electrocardiographic recording. Sedentary individuals were
instructed to perform their habitual daily life activities.
Recordings were reviewed by 2 cardiologists (A.Z., A.C.): in
particular, every single ectopic beat, pause, or artifact and all
Clinical Perspective
What Is New?
• By comparing the burden of ventricular arrhythmias (VAs) at
24-hour 12-lead ambulatory electrocardiographic monitor-
ing in young competitive athletes and sedentary individuals,
we found that the proportion of subjects showing frequent
or complex arrhythmias was low and similar in the 2 groups.
• The presence of VAs was unrelated to the intensity of
physical training, years of sports activity, type of sport, and
degree of left ventricular remodeling, as evidenced by
echocardiography.
• A subset of apparently healthy athletes with right bundle
branch block–like complex and/or exercise-induced VA
showed late enhancement at cardiac magnetic resonance
with a nonischemic distribution.
What Are the Clinical Implications?
• VAs in young athletes should not be simply dismissed as
part of the adaptive changes of the heart to regular sport
activity (“athlete’s heart”) but, similar to the general
population, they should be interpreted as a possible sign
of an underlying disease.
• Evaluation of VA morphologic features, complexity, and
relation to exercise, rather than the count of premature
ventricular beats, is useful for differentiating between
benign and other potentially pathologic variants.
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families of normal beats were confirmed manually. Recordings
with >2 hours of artifacts or missing signals were considered
inadequate and repeated.
The VA burden was graded as follows: 1 indicates no PVBs;
2, 1 to 10 isolated PVBs and no complex VAs; 3, 11 to 100
isolated PVBs and no complex VAs; 4, >100 isolated PVBs and
no complex VAs; 5, ≥1 couplet or triplet; and 6, nonsustained
VT. The PVB morphologic features were classified as left
bundle branch block like (LBBB) if the ectopic QRS complex
was predominantly negative in lead V1 or right bundle branch
block like (RBBB) if the ectopic QRS complex was predom-
inantly positive or isodiphasic in lead V1. PVBs with a LBBB/
inferior axis (positive QRS complex in aVF and negative QRS
complex in V1 and aVL) configuration were considered of
ventricular outflow tract origin; PVBs with a QRS duration
≤130 ms resembling a typical RBBB/left or right axis
deviation were considered of fascicular origin.12,14 PVBs with
≥2 morphologic features that accounted for ≥10% of all PVBs
were classified as polymorphic.
Imaging Evaluation
Echocardiography was performed in all athletes with >10
isolated PVBs/hour or ≥1 complex VA. According to previous
studies indicating that cardiovascular diseases are more
commonly observed in athletes with frequent (>500 PVBs/24
hours), exercise-induced, or complex VAs, further imaging
study by CMR was reserved to athletes fulfilling these
arrhythmic criteria, in addition to those with abnormal
echocardiographic findings.5,15–17 Echocardiography and
CMR were also performed in a control group of athletes with
no or rare (≤10) isolated PVBs matched with a 1:1 ratio for
sex, age class, and type of sport, who volunteered to
participate.
Echocardiography
Using a standardized protocol, all examinations were per-
formed by 3 cardiologists with experience in research
echocardiography (L.P.B., D.M., and A.N.) using a commer-
cially available Vivid E9 ultrasound machine (GE Vingmed
Ultrasound AS, Horten, Norway) equipped with a M5S probe.
All patients were examined in the left lateral position using
grayscale second-harmonic 2-dimensional imaging, with the
adjustment of image contrast, frequency, depth, and sector
size for adequate frame rate and optimal left ventricular (LV)
border visualization. All echocardiographic measurements
were obtained and recorded according with current
recommendations.18
Measurements of diastolic and systolic dimensions of the
LV, right ventricle, left atrium, and right atrium and measure of
the aorta were obtained from parasternal long-axis view and
standard apical views. Care was taken to avoid LV
foreshortening in both apical views, and images were
recorded during breath holding to minimize respiratory
movements. The apical 4-chamber view was used for the
measurement of LV myocardial function with color tissue
Doppler, and sample volumes were located at the lateral and
septal mitral annulus for pulsed tissue Doppler measurements
of the systolic and diastolic velocities. All tracings and
recordings contained at least 3 cardiac cycles to allow
averaging of measurements.
Cardiac magnetic resonance
CMR was performed with 1.5-T systems (Magnetom Avanto
[Siemens Medical Solutions, Germany]; Achieva [Philips North
American Corporation]) using dedicated software, a phased-
array surface receiver coil, and vectocardiogram trigger.
According to the protocols recommended by the Society for
Cardiovascular Magnetic Resonance,19 we acquired steady-
state free precession sequence (true FISP) cine images in
sequential short-axis views (slice thickness, 6 mm; gap, 0 mm),
standard 4-, 3-, and 2-chamber views, a long-axis view of the
right ventricle, and a dedicated view for the right ventricular
outflow tract. LV volume, wall thickness, and systolic function
were calculated from the short-axis cine images, excluding
papillary muscles from the myocardium.
For detection of myocardial edema, T2 triple inversion
recovery sequences were applied before contrast administra-
tion and acquired at the same location as cine images. The
presence of myocardial edema on T2-weighted images was
diagnosed using a dark blood preparation on sequences to
reduce artifacts and surface coil reception field inhomogene-
ity; moreover, to avoid misdiagnosis of subendocardial edema
resulting from “slow-flow artifacts,” T2-weighted images were
compared with the corresponding cine images, using a side-
by-side approach on the same cardiac phase. Semiquantita-
tive analysis was performed using regional T2-ratio method,
and myocardial edema was diagnosed in the presence of an
increased signal intensity (ie, >2 SDs above skeletal muscle),
as recommended.19 All edematous regions were confirmed in
2 perpendicular views. Ten minutes after IV administration of
contrast agent (gadobenate dimeglumine; Multihance; Bracco;
0.2 mmol/kg of body weight), 2-dimensional segmented fast
low-angle shot inversion recovery sequences were acquired in
the same views of cine images, covering the entire ventricles.
Inversion times were adjusted to null normal myocardium
using the Look-Locker sequence, and images were repeated
in 2 separate phase-encoding directions to exclude artifacts.
Myocardial late gadolinium enhancement (LGE) was assessed
with an automated thresholding and considered present if
signal intensity was >3 SDs above remote myocardium in 2
orthogonal views.19 Isolated junctional LGE was not consid-
ered because it is a common and nonpathologic finding in
athletes.20
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The images of CMR were evaluated and analyzed indepen-
dently by 2 observers (M.D.L., M.P.M.), blinded to clinical
findings, ECG features, and coronary angiography findings,
with the use of dedicated software (CMR42; Circle Cardio-
vascular Imaging Inc). In case of disagreement, a third
observer was consulted.
Statistical Analysis
Continuous and categorical variables were expressed as
median (with 25th–75th percentiles) and number (percent-
age), respectively. Categorical variables were compared
using the v2 or Fisher exact test, as appropriate. Continuous
data were compared using the Mann-Whitney U test because
normality could not be assumed for any variable.
Unweighted and weighted (for age class and sex) odds
ratios (with 95% confidence intervals) were calculated using
the Cochran-Mantel-Haenszel method for the primary end
point analysis. Instead, matching factors were not accounted
for in the statistical analysis when athletes with and without
VA who underwent imaging investigation were compared,
because of the small sample size. P<0.05 was considered
statistically significant. Data were analyzed with SPSS,
version 23 (IBM). Study data were collected and managed
using REDCap electronic data capture tools, hosted at
University of Padova (Padova, Italy).
Results
Characteristics of the Study Cohorts
During the 18-month study period, 1377 young athletes (aged
15 to 35 years) underwent preparticipation screening. Of
those athletes, 125 did not meet the enrollment criteria
because they were engaged in sports at low cardiovascular
demand (N=90), had cognitive deficits (N=19), or were
considered not eligible for competitive sports activity because
of a cardiovascular disease (N=16). Of the remaining 1268
young athletes, 288 (median age, 21.00 [25th–75th per-
centile, 19.00–25.00] years; 71% males) agreed to participate
in the study. Athletes who did and those who did not agree to
participate in the study did not differ in terms of age (21
versus 20 years old; P=0.34), male sex (71% versus 69%;
P=0.55), and type of sports activity (endurance versus
nonendurance) (56% versus 52%; P=0.25). The athletic cohort
practiced a variety of sports, including soccer (N=72 [25%]),
volleyball (N=43 [15%]), running (N=36 [13%]), rugby (N=17
[6%]), basketball (N=14 [5%]), cycling (N=14 [5%]), triathlon
(N=11 [4%]), swimming (N=11 [4%]), martial arts (N=10 [3%]),
tennis (N=10 [3%]), and other sports (N=50 [18%]). The
control group included 144 subjects (median age, 22.00
[25th–75th percentile, 20.00–24.00] years; 71% males). The
family history was positive for coronary artery disease,
premature sudden death, or cardiomyopathies in 75 athletes
(26%) and 27 sedentary individuals (19%; P=0.09). Palpitations
were reported by 7 athletes (2%) and 12 sedentary individuals
(8%; P=0.005). A history of mitral valve prolapse with no or
mild regurgitation was reported by 4 athletes (1%) and 2
sedentary individuals (1%; P=1.0), whereas no athlete or
control subject reported previous myocarditis or pericarditis.
Ambulatory Electrocardiographic Monitoring (24
Hour and 12 Lead)
Ventricular arrhythmic burden in athletes and
sedentary individuals
Table 1 shows the grading of VAs in young athletes and
sedentary individuals. At least 1 PVB was recorded by 24-hour
12-lead ambulatory electrocardiographic monitoring in 170
athletes (59%) and 57 sedentary individuals (40%; P<0.001),
and at least 1 complex VA (couplet, triplet, or nonsustained
VT) was recorded in 16 athletes (6%) and 8 sedentary
individuals (6%; P=1.0). Compared with sedentary individuals,
athletes significantly more often showed rare (≤10) and
isolated PVBs (142 [49%] versus 41 [28%]; P<0.001), whereas
there was no difference in the prevalence of more frequent or
complex VAs.
The proportion of athletes and sedentary individuals with
>10 isolated PVBs/hour or ≥1 complex VA was similar (28
[10%] versus 16 [11%] [P=0.62]; unweighted odds ratio, 0.85
[95% C.I. 0.44–1.62] [P=0.62]; weighted odds ratio, 0.86
[95% C.I. 0.44–1.64] [P=0.68]). The prevalence of athletes
and sedentary individuals with >10 isolated PVBs/hour or ≥1
complex VA in each age and sex subgroup is provided in
Table S1.
The burden of VAs did not differ between subjects with and
without a history of palpitations, both in the athletic and
sedentary control cohorts (Table S2).
Table 1. Comparison Between the Burden of VAs at 24-Hour
Ambulatory Electrocardiographic Monitoring in Athletes and
Sedentary Individuals
Variable Athletes (N=288)
Sedentary
Individuals
(N=144) P Value
No PVBs 118 (41) 88 (61) <0.001
1–10 Isolated PVBs 142 (49) 41 (28) <0.001
11–100 Isolated PVBs 2 (1) 3 (2) 0.34
>100 Isolated PVBs 10 (3) 5 (3) 1.0
≥1 Couplet or triplet 10 (3) 5 (3) 1.0
≥1 Run (≥4 beats) 6 (2) 3 (2) 1.0
Data are given as number (percentage). PVB indicates premature ventricular beat; VA,
ventricular arrhythmia.
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Impact of age, sex, and type and intensity of physical
exercise on the arrhythmic burden
Athletes with >10 isolated PVBs/hour or ≥1 complex VA were
older (median age, 26 versus 20 years; P=0.008) but did not
differ with regard to sex, type of sport, hours of training, and
years of sports activity compared with other athletes
(Table 2). Characteristics of VA according to sex in the 28
athletes with >10 isolated PVBs/hour or ≥1 complex VA are
shown in Table S3.
Morphologic features of VAs
Among the 142 athletes with 1 to 10 isolated PVBs (median, 2
[25th–75th percentile, 1–3] PVBs), the following predominant
PVBmorphologic features were identified: outflow tract (LBBB/
inferior axis) in 54 athletes (38%), fascicular (RBBB and QRS
duration ≤130 ms) in 22 athletes (15%); LBBB/intermediate or
superior axis in 31 athletes (22%); and RBBB and QRS duration
>130 ms in 15 athletes (11%). The remaining 20 athletes (14%)
had polymorphic PVBs.
Of the 28 athletes with >10 isolated PVBs or ≥1 complex VA
(median, 63 [25th–75th percentile, 4–400] PVBs), 11 (39%)
showed outflow tract PVBs and 4 (14%) showed fascicular PVBs;
the remaining 13 athletes showed VAs with a RBBB configu-
ration and QRS duration >130 ms (N=5 [19%]), LBBB config-
uration and intermediate or superior axis (N=6 [21%]) or
polymorphic VAs (N=2 [7%]). Athletes with outflow tract or
fascicular arrhythmias showed a higher number of PVBs
(median, 200 [25th–75th percentile, 4–580] versus 12 [25th–
75th percentile, 4–141]; P<0.001) but a lower prevalence of ≥1
complex VA (3/15 [20%] versus 13/13 [100%]; P<0.001)
compared with athletes with other arrhythmia morphologic
features. Six athletes showed>500 PVBs/24 hours, associated
with ≥1 complex VA in 4: 5 with an outflow tract morphologic
feature and 1 with a fascicular morphologic feature.
Short runs of nonsustained VT (range, 4–6 beats) occurred
in 6 athletes; the morphologic features of the QRS during VT
were RBBB in 3 (including 1 that occurred during sports
activity) and LBBB in 3 (including 2 that occurred during
sports activity).
Imaging Studies
Echocardiography was performed in all 28 athletes with >10
isolated PVBs or ≥1 complex VA and in 28 control athletes
matched for age, sex, and sport discipline with no or ≤10
isolated PVBs (Table 3). No athletes (with or without >10
isolated PVBs or ≥1 complex VA) had moderate or severe
dilatation, either atrial or ventricular, systolic ventricular
dysfunction, abnormal LV filling pattern, or relevant valvular
and aortic disease.
By study design, additional CMR was performed in 17
athletes because of frequent (>500 PVBs/24 hours), exercise-
induced, or complex VAs and in 17 control athletes with no or
≤10 isolated PVBs matched for age, sex, and type of sport
discipline (Table 4). Among the 17 athletes with VA, 4 showed
PVBs with a LBBB/inferior axis morphologic feature (suggest-
ing outflow tract origin), 6 showed a LBBB/intermediate or
superior axis configuration (suggesting right ventricular free
wall origin), 5 showed an RBBB configuration and QRS
duration >130 ms (suggesting LV free wall origin), and 2
showed polymorphic (both RBBB and LBBB) arrhythmias.
All athletes (with or without VAs) exhibited normal wall
thickness, cavity size, and systolic ventricular function.
Isolated LV LGE with a nonischemic distribution (ie, midmy-
ocardial or subepicardial) was distinctively found in 3 athletes
with VAs. The clinical characteristics of the 3 athletes with LV
LGE are summarized in Table 5 and shown in Figures 1
through 3. Of 7 athletes, 3 (43%) with RBBB or polymorphic
VAs showed LV LGE compared with 0 of the 10 athletes with
LBBB morphologic feature of VA (P=0.05). In all 3 athletes
with LV LGE, the ectopic QRS morphologic feature and axis
were concordant with the regional distribution of the
myocardial lesion.
Table 2. Comparison Between Athletes With and Without
>10 Isolated PVBs or ≥1 Complex VA at 24-Hour Ambulatory
Electrocardiographic Monitoring With Regard to Age, Sex, and
Sports Activity
Variable
Athletes With
>10 Isolated
PVBs or ≥1
Complex VA
(N=28)
Athletes With
≤10 Isolated
PVBs and No
Complex VA
(N=260) P Value
Male sex 21 (75) 181 (70) 0.55
Age, y 26 (19–31) 20 (17–25) 0.008
Training time, h/wk 7 (6–9) 8 (6–10) 0.12
Training time, h/y 330 (280–415) 350 (310–455) 0.16
Sports practice, y 7 (3–10) 8 (4–11) 0.63
Highly dynamic
(endurance) sport*
19 (68) 142 (55) 0.18
Mean heart rate, bpm 70 (63–75) 72 (67–76) 0.20
Minimum heart rate,
bpm
39 (35–43) 40 (37–43) 0.33
Maximum heart rate,
bpm
176 (166–182) 170 (158–184) 0.53
Positive family
history†
3 (11) 72 (28) 0.07
Previous palpitations 1 (4) 6 (2) 0.51
Data are given as number (percentage) or median (25th–75th percentile). BPM indicates
beats per minute; PVB, premature ventricular beat; VA, ventricular arrhythmia.
*According to the classification of Mitchell et al.13
†For premature (<40 years old in men and <50 years old in women) sudden death,
inherited cardiomyopathies, or coronary artery disease.
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The 3 athletes with complex and/or exercised-induced VAs
and underlying LV LGE were prescribed b blockers and advised
to limit sports activity. Over a period of follow-up of 18, 15, and
9 months, respectively, the outcome was uneventful in all.
Discussion
Our study evaluated, for the first time, the VA burden by 12-lead
24-hour ambulatory electrocardiographic monitoring (including
a training session) in a large sample of young athletes who were
considered eligible for competitive sports activity at prepartic-
ipation screening and in a group of sedentary individuals. The
aim was to assess whether VAs were more prevalent in young
competitive athletes than sedentary individuals; showed a
relation to the intensity of physical training, type of sport, and
years of activity; and associated with an underlying pathologic
myocardial substrate. Themain findings were as follows: (1) the
proportion of athletes showing >10 isolated PVBs or ≥1
complex VA was low (10%) and similar to that of sedentary
individuals; (2) VAs were unrelated to the intensity of physical
training, years of sports activity, type of sport (endurance
versus nonendurance), and degree of LV remodeling, as
evidenced by echocardiography; (3) although echocardio-
graphic examination did not show any pathologic substrate,
contrast-enhanced CMR unmasked an underlying nonischemic
LV LGE, suggestingmyocardial fibrosis in a subset of apparently
healthy athletes with RBBB-like complex and/or exercise-
induced VAs (Figure 4).
Prevalence and Determinants of VAs in Athletes
There are conflicting results of previous studies addressing
the proarrhythmic effect of sports activity with regular
exercise and competition. Biffi et al reported on a group of
355 elite athletes who underwent 24-hour ambulatory
Table 3. Echocardiographic Findings in Athletes With >10
Isolated PVBs or ≥1 Complex VA at 24-Hour Ambulatory
Electrocardiographic Monitoring and Control Athletes
Variable
Athletes With
>10 Isolated
PVBs or ≥1
Complex VA
(N=28)
Control Athletes
With ≤10
Isolated PVBs
(N=28) P Value
LA volume, mL/m2 33 (28–37) 30 (26–33) 0.47
LA volume
≥36 mL/m2
8 (28.6) 5 (17.9) 0.34
RA volume, mL/m2 29 (22–38) 25 (22–35) 0.29
RA volume
≥36 mL/m2
9 (32.1) 6 (21.4) 0.37
LV septal
thickness, mm
9 (8–9) 8 (8–9) 0.47
LV end-diastolic
diameter, mm
49 (46–52) 48 (41–54) 0.73
LV posterior wall
thickness, mm
9 (8–10) 9 (8–9) 0.62
LV EF, % 63 (59–65) 62 (61–64) 0.73
LV EF <53% 0 0 
LV EDV, mL/m2 67 (55–73) 62 (56–74) 0.36
LV EDV >75 mL/m2 6 (21.4) 7 (25.0) 0.75
Regional LV WMA 0 0 
Abnormal LV filling
pattern
0 0 
RV FAC, % 39 (38–46) 42 (41–48) 0.36
RV FAC <35% 0 0 
RV EDA, cm2 12.3 (11.3–13.2) 11.7 (10.8–12.6) 0.68
RV EDA >12 cm2/m2 8 (28.6) 6 (21.4) 0.5
Regional RV WMA 0 0 
Mild ascending aorta
dilation
1 (3.6) 0 1.0
Data are given as median (25th–75th percentile) or number (percentage). EDA indicates
end-diastolic area; EDV, end-diastolic volume; EF, ejection fraction; FAC, fractional area
change; LA, left atrium; LV, left ventricular; PVB, premature ventricular beat; RA, right
atrium; RV, right ventricular; VA, ventricular arrhythmia; WMA, wall motion abnormality.
Table 4. CMR Findings in Athletes With Frequent PVBs
(>500/24 Hours), PVBs Induced by Exercise or Complex VA,
at 24-Hour Ambulatory Electrocardiographic Monitoring and
Control Athletes
Variable
Athletes With
Frequent PVBs
(>500/24 Hours),
PVBs Induced
by Exercise
or Complex
VA (N=17)
Control Athletes
With <10 Isolated
PVBs (N=17) P Value
LV EDV, mL/mq 85 (76–94) 87 (78–97) 0.73
LV EF, % 61 (56–68) 58 (57–64) 0.43
Maximum LV wall
thickness, mm
9 (8–10) 9 (8–9) 0.84
Regional LV WMA 0 0 
RV EDV, mL/mq 86 (74–93) 82 (76–95) 0.64
RV EF, % 55 (51–63) 59 (57–67) 0.38
Regional RV WMA 0 0 
LV myocardial edema 0 0 
LV LGE* 3 (18) 0 0.23
RV LGE 0 0 
Pericardial LGE 0 0 
Data are given as median (25th–75th percentile) or number (percentage). CMR indicates
cardiac magnetic resonance; EDV, end-diastolic volume; EF, ejection fraction; LGE, late
gadolinium enhancement; LV, left ventricular; PVB, premature ventricular beat; RV, right
ventricular; VA, ventricular arrhythmia; WMA, wall motion abnormality.
*Excluding isolated junctional LGE.
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electrocardiographic monitoring because of PVBs at baseline
ECG or palpitations.5 This group represented 2.3% of all
athletes who were evaluated at the Institute of Sports Science
of the Italian National Olympic Committee. Among them, 71
athletes (corresponding to 0.4% of all screened athletes)
exhibited >2000 PVBs or nonsustained VT. In this study, most
athletes with VAs had no evidence of underlying structural
abnormalities, the arrhythmias tended to decrease after
detraining, and the follow-up was uneventful: all these findings
are consistent with the concept that VAs may be considered a
feature of the “athlete’s heart.”4,5 Moreover, Palatini et al
compared 40 endurance athletes with 40 sedentary individ-
uals and found that the prevalence of complex VAs at
ambulatory electrocardiographic monitoring was higher in
trained individuals.10 Other studies comparing the prevalence
of VA at 24-hour ambulatory electrocardiographic monitoring
in healthy athletes versus sedentary individuals disproved the
concept of a proarrhythmic effect of sports activity by
demonstrating that only a minority of athletes exhibited
frequent or complex VAs with a prevalence that did not differ
Table 5. Characteristics of Athletes With VAs and Late Enhancement at CMR
Age, y Sex Sport
Family and
Personal History
24-h Ambulatory Electrocardiographic
Monitoring LGE Pattern and Distribution Figures
17 M Running Negative 49 Isolated PVBs and 2 couplets
with a RBBB configuration
predominantly during exercise
Subepicardial/midmyocardial stria
involving the basal portion of the
inferolateral left ventricular wall
1
31 M Basketball Negative 1 Couplet with a LBBB/superior axis
configuration at rest and 1 run of
nonsustained ventricular
tachycardia (6 beats) with a RBBB
morphologic feature during
exercise
Midmyocardial stria involving the
basal portion of the inferolateral
left ventricular wall
2
24 M Rugby Negative 27 Isolated PVBs with a RBBB
configuration during exercise
Midmyocardial stria involving the
basal inferior wall
3
CMR indicates cardiac magnetic resonance; LBBB, left bundle branch block; LGE, late gadolinium enhancement; M, male; PVB, premature ventricular beat; RBBB, right bundle branch block;
VA, ventricular arrhythmia.
Figure 1. Nonischemic left ventricular late enhancement in a 17-year-old runner. Postcontrast cardiac magnetic resonance, short-axis, and 3-
chamber long-axis views at baseline (A and B) and after 6 months of follow-up (C and D), demonstrating a “stria” of late gadolinium
enhancement with a subepicardial/midmyocardial distribution (suggesting nonischemic origin) involving the basal portion of the inferolateral left
ventricular wall. E, The ambulatory 24-hour electrocardiographic monitoring demonstrated exercise-induced complex ventricular arrhythmias
with a right bundle branch block configuration, consistent with a left ventricular origin, both at baseline and at follow-up.
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with that of their sedentary counterpart6–9,11 (Table S4). In
addition, Delise et al reported that the proportion of athletes
with VAs who showed a reduction in the arrhythmic burden
during follow-up was similar in a group undergoing detraining
and in a group who continued training.21
At variance with the present study, previous investigations
performed in the 1980s and 1990s enrolled smaller cohort of
athletes, lacked imaging evaluation (with the exception of one
study, which reported echocardiography findings), and did not
assess the determinants of VAs. Most important, our study
was the first to use a 12-lead ambulatory electrocardiographic
monitoring system. The results of our study confirmed and
extended previous observations against the proarrhythmic
effect of regular training in young athletes by showing that the
proportion of athletes showing >10 isolated PVBs or ≥1
complex VA (ie, couplet, triplet, or nonsustained VT) was low
and similar to sedentary individuals (10% versus 11%) and that
the VA burden in the athletes group was unrelated to the
duration and intensity of sports activity as well as to the degree
of training-induced LV remodeling at echocardiography. This
latter finding is an agreement with a previous study on 175 top-
level athletes without cardiovascular abnormalities showing
that the VA burden was not associated with the degree of
adaptive LV hypertrophy.22
Interestingly, we found that the prevalence of rare PVBs
(<10/day) was significantly higher in athletes than in
sedentary individuals. Whether this finding represents an
early sign of cardiac adaption to the strains of athletic
workouts needs to be confirmed by further studies focused on
older athletic population, given the relationship between
increasing age and worsening arrhythmic burden observed in
the present investigation.
Morphologic Features of VAs in Athletes
ECG is an important screening test for identification of leading
causes of SCD in young competitive athletes. However, some
at-risk arrhythmogenic diseases, such as focal myocarditis,
early/minor cardiomyopathy, and segmental nonischemic LV
scar, may be associated with a normal ECG.1,20,23,24 Our
study is unique in that ambulatory electrocardiographic
monitoring used a 12-lead configuration system: that offers
the potential to increase the screening sensitivity for identi-
fication of these ECG-undetectable concealed arrhythmic
substrates by showing not only the presence but also the
morphologic features of VAs. This latter characteristic
provides important information about their site of origin,
mechanism, and possible underlying substrate.12
Figure 2. Left ventricular late enhancement in a 30-year-old basketball player. Postcontrast cardiac
magnetic resonance short-axis (A) and 2-chamber long-axis (B) views demonstrating an intramural “stria” of
late gadolinium enhancement involving the basal and mid portion of the inferior left ventricular wall. C, The
ambulatory 24-hour electrocardiographic monitoring demonstrated an exercise-induced run of nonsus-
tained ventricular tachycardia with a left bundle branch block configuration, consistent with a left
ventricular origin.
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Our results are in keeping with those of previous studies
suggesting that frequent isolated PVBs in young athletes most
commonly show infundibular or fascicular morphologic fea-
tures, which denote benign arrhythmias caused by automatic
foci in the absence of a pathologicmyocardial substrate that are
usually suppressed by exercise.12,14 Indeed, using 12-lead
electrocardiographic monitoring, we found that all athletes with
>500 PVBs/24 hours had either an infundibular or fascicular
morphologic feature. All athletes with these VA morphologic
features had normal imaging evaluation, including echocardio-
graphy and CMR. On the other hand, 13 of our 16 athletes with
complex VA (couplets, triplets, or nonsustained VT) exhibited an
ectopic QRS morphologic feature other than infundibular or
fascicular. These VA variants are less common and possibly
associated with an underlying disease.12
Arrhythmic Substrates
CMR is increasingly used in the evaluation of athletes with
apparently idiopathic VAs because it may increase the sensi-
tivity of identifying concealed arrhythmogenic substrates,
thanks to its tissue characterization ability.14 According to a
prespecified study protocol, we reserved CMR in case of
frequent, complex, or exercise-induced arrhythmias, which are
a recognized subgroup with high risk of underlying cardiovas-
cular disease.5,15–17 In 3 of these athletes, postcontrast CMR
sequences allowed identification of LV LGE with a subepicar-
dial/midmyocardial (ie, nonischemic) pattern, which was not
associated with wall motion abnormalities detectable by either
echocardiography or cine-CMR because of its segmental
distribution confined to the outer layer of LV musculature. All
3 athletes exhibited arrhythmias with a RBBB configuration,
which was concordant with the LV location of LGE, whereas
CMR was negative in all athletes with LBBB arrhythmias and
control athletes. These findings are in agreement with previous
studies showing that a RBBB-likemorphologic feature of VA, but
not LBBB, predicts the presence of an underlying LV scar.20,25
Moreover, in athletes showing VA with a LBBB morphologic
feature, no abnormalities of the right ventricle were evidenced
by both echocardiography and CMR using dedicated morpho-
functional and postcontrast views.
The clinical relevance of this finding is that nonischemic LV
scar is an increasingly reported cause of life-threatening VAs
and SCD in the athletes, often undetected by routine
electrocardiographic and echocardiographic screening.1,20
However, this perspective is based on previous observations
on selected athletes who were referred to tertiary center or
experienced cardiac arrest. The risk of SCD during sports
Figure 3. Left ventricular late enhancement in a 24-year-old rugby player. Postcontrast cardiac magnetic
resonance short-axis (A) and 3-chamber long-axis (B) views demonstrating an intramural “stria” of late
gadolinium enhancement involving the basal portion of the inferior left ventricular wall. C, The ambulatory
24-hour electrocardiographic monitoring demonstrated exercise-induced isolated premature ventricular
beats with a right bundle branch block configuration, consistent with a left ventricular origin.
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activity and recommendations for sports eligibility of the low
(but not negligible, 1%) proportion of our asymptomatic
athletes with VA and LV LGE remain to be established.
Study Limitations
The main limitation is that we enrolled a cohort of volunteers
rather than a consecutive series of athletes undergoing prepar-
ticipation screening. Although baseline characteristics of those
who did and did not agree to participate were similar, we cannot
exclude a selection bias. Because sedentary individuals were
also recruited on a voluntary basis, they may not be represen-
tative of the general sedentary population. Moreover, the study
included Italian white athletes and, thus, the study results may
not be generalized to athletes of other countries and ethnicities.
Recruitment of a larger group of athletes than sedentary
individuals, which was determined by logistical reasons, may
have influenced the matching efficiency. Although
echocardiography and CMR studies were not performed
systematically in the athletic population, the threshold for
imaging investigation in athletes with VAs was low, and a
comparable group of control athletes with no VAs underwent
imaging study. On the other hand, the correlation between VA
characteristics and underlying myocardial substrate in the
population of sedentary individuals was beyond the scope of
the study.
Conclusions
At variance with a traditional perspective that VAs are a
consequence of the structural and neuroautonomic remodeling
of the athlete’s heart, our study showed that the prevalence of
VAs in young competitive athletes is low, similar to that of
sedentary individuals and unrelated to the type and intensity of
sports activity. Similar to the nonathletic general population,
VAs in the athletes may be associated with an underlying
Figure 4. Summary of the study methods and main findings. LBBB indicates left bundle branch block;
LGE, late gadolinium enhancement; LV, left ventricular; NSVT, nonsustained ventricular tachycardia; PVB,
premature ventricular beat; RBBB, right bundle branch block; VA, ventricular arrhythmia.
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myocardial substrate potentially at risk of SCD. Current
guidelines recommend that athletes with VAs should undergo
further clinical and imaging workup to exclude an underlying
pathologic substrate on the basis of a high number and
complexity of PVBs.2,3 Our results suggest that a multipara-
metric approach considering VA morphologic features, com-
plexity, and relation to exercise, rather than the PVBs count
alone, is useful for differentiating between benign and other
potentially pathologic variants. In particular, demonstration of
complex or exercise-induced PVBs with a RBBB morphologic
feature should enable accurate clinical evaluation, including
CMR, to exclude a concealed LV myocardial scar. Whether the
ambulatory electrocardiographic monitoring should become
systematically part of preparticipation evaluation of athletes
goes beyond the scope of our pathophysiological study;
however, our findings suggest that when ambulatory electro-
cardiographic monitoring is performed in athletes with VAs, it
should have a 12-lead configuration and include an exercise
session.
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Table S1. Prevalence of athletes and sedentary controls showing >10 isolated premature ventricular beats or ≥1 complex ventricular 
arrhythmias according to sex and age class. 
 
  Athletes Sedentary control 
Female sex ≤25 y.o. 2/62 (3%) 2/31 (6%) 
 > 25 y.o. 5/24 (21%) 2/12 (17%) 
Male sex ≤ 25 y.o. 9/134 (7%) 5/67 (7%) 
 > 25 y.o. 12/68 (17%) 7/34 (21%) 
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Table S2. Comparison between the burden of ventricular arrhythmias at 24-hours 12-leads ambulatory ECG monitoring in 
athletes and controls with and without a history of palpitations. 
 
 Athletes Sedentary controls 
 History of 
palpitations 
(N=7) 
No history of 
palpitations 
(N=281) 
History of 
palpitations 
(N=12) 
No history of 
palpitations 
(N=132) 
No PVBs 3 (43%) 115 (41%) 9 (75%) 79 (60%) 
1-10 isolated PVBs 3 (43%) 139 (49%) 3 (25%) 38 (29%) 
11-100 isolated PVBs 0 2 (1%) 0 3 (2%) 
> 100 isolated PVBs 0 10 (4%) 0 5 (4%) 
≥1 couplet or triplet 1 (14%) 9 (3%) 0 5 (4%) 
≥1 run (≥4 beats) 0 6 (2%) 0 3 (2%) 
P value 0.65 0.84 
 
  
D
ow
nloaded from
 http://ahajournals.org by on April 5, 2019
Table S3. Ventricular arrhythmias grading and prevalent morphology in the subgroup of 28 athletes with >10 isolated PVBs/hour 
or ≥1 complex VA according to sex.    
  Females 
N=7 
Males 
N=21 
p 
VA grading 
11-100 isolated PVBs 
> isolated PVBs 
Couplets or triplets 
Non-sustained VT 
 
1 (14%) 
2 (29%) 
1 (14%) 
3 (43%)  
 
1 (5%) 
8 (38%) 
9 (43%) 
3 (14%) 
 
0.26 
VA morphology 
Outflow tract 
Fascicular 
LBBB and intermediate or superior axis 
RBBB QRS duration >130 ms. 
Polymorphic 
 
3 (43%) 
1 (14%) 
2 (29%) 
1 (14%) 
0 
 
8 (38%) 
3 (14%) 
4 (19%) 
4 (19%) 
2 (10%) 
 
0.48 
PVBs=premature ventricular beats; LBBB=left bundle branch block; RBBB=right bundle branch block; VA=ventricular 
arrhythmias  
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Table S4. Summary of previous studies comparing the burden of ventricular arrhythmias in athletes and sedentary controls. 
Reference N. 
athletes/ 
controls 
Type of athletes Prevalence of arrhythmias Imaging for  
underlying heart 
disease 
Viitasalio,  
Br Heart J 19821 
35/35 Young endurance 
(23±6 y.o.) 
 
29% athletes versus 31% controls had rare isolated PVBs 
(p=0.79);  
6% athletes versus 11% controls had frequent PVBs or 
complex VA (p=0.67) 
N/A 
Viitasalo,  
Eur Heart J suppl 
19842 
35/35 Teenager athletes 
(14-16 y.o.) 
60% of athletes versus 57% of controls had at least 1 PVB 
(p=0.80) 
N/A 
Talan,  
Chest 19823 
20/50 Young (19-29 
y.o.) long-distance 
runners 
70% of athletes versus 50% of controls had ≥1 PVB (p=0.13) 
10% of athletes versus 6% of controls had >50 PVBs or 
complex VA (p=1.0) 
N/A 
Pilcher,  
Am J cardiol 19834 
80/0 Young (mean 30 
y.o.) runners 
50% athletes at least 1 PVB, 7.5% >50/die, 4% repetitive N/A 
Palatini,  
Am Heart J 19855 
40/40 Young endurance 
(20±7 y.o.) 
70% of athletes versus 55% of controls had ≥1 PVB (p=0.17) 
13% athletes vs 0% controls had >30 PVBs or complex VA 
(p=0.12) 
Echocardiography: 
negative in all 
Bjornstad, 
Cardiology 19946 
60/30 Young No differences between cases and controls in rare PVBs. No 
complex forms. 
N/A 
y.o.= year-old; PVB=premature ventricular beats; VA=ventricular arrhythmias.  Complex VA are defined as couplets, triplets or NSVT
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